Blog Posts focused on: Jane H Buckner, MD; Lab Buckner

Mystery Of Multiple Autoimmune Diseases
Lauren Lippincott is not yet 35 years old, yet she lives with five autoimmune diseases. She’s not alone. About 25 percent of people with autoimmune diseases have a tendency to develop additional autoimmune diseases.

Turning the Tide in Lupus Research
As people who are affected by lupus know, it is one of the most puzzling and complex autoimmune diseases, according to Benaroya Research Institute scientists and Virginia Mason clinical researchers. Diagnosis is difficult because it can affect all the systems of the body.

Immunotherapy to Cure Type 1 Diabetes
Researchers at Benaroya Research Institute at Virginia Mason (BRI) and Seattle Children’s Research Institute are making key progress in their quest for an immunotherapy that cures type 1 diabetes once and for all.

Three Sisters Honor Their Mother
Three sisters, Jeanne, Marilyn and Carol Kleyn, all joined the early research project SERA and the follow-up TIP-RA study. Their mother Peggy Kleyn was diagnosed with RA around 76 years of age.

Exciting Breakthroughs in Preventing Rheumatoid Arthritis
What does it mean when scientists say they want to “prevent” a disease?

Leading a New Center for Asthma and Allergy Research
The National Institutes of Health recently awarded BRI an $8 million grant to lead the center—a collaboration of researchers from BRI, UW Medicine and Seattle Children’s Research Institute.

New Approaches to Eliminating RA
Benaroya Research Institute at Virginia Mason (BRI) is waging a comprehensive fight against rheumatoid arthritis (RA). “During the last 15 years, treatments for RA have improved enormously with new therapies,” says BRI President Jane Buckner, MD, who is leading this work.

Murdock Trust Gives 30 Years of Support
"If it wasn’t for the Murdock Trust helping us with essential pieces of equipment and new technology for over 30 years, we wouldn’t have been able to achieve our cutting-edge research advancements,” says BRI President Jane Buckner, MD.

Good News for Lungs, Bad News for Allergies and Asthma
One in four people in the United States grapple with allergies, asthma or both. For years, BRI has had its sights set on helping these patients breathe easier. And our efforts just got a huge and welcome boost.

Gene Editing Aims to Control T1D
Benaroya Research Institute (BRI) and Seattle Children’s Research Institute (SCRI) are pioneering the use of gene editing techniques in efforts to control type 1 diabetes (T1D).